Use of tranexamic acid in major trauma: a sex-disaggregated analysis of the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2 and CRASH-3) trials and UK trauma registry (Trauma and Audit Research Network) data. (2022)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bja.2022.03.032
PubMed Identifier: 35597623
Publication URI: http://europepmc.org/abstract/MED/35597623
Type: Journal Article/Review
Volume: 129
Parent Publication: British journal of anaesthesia
Issue: 2
ISSN: 0007-0912